Monday 14 September 2020

8.00 – 8.30

On site registration and welcome

8.30 – 9.00

Vasculogenesis and angiogenesis

T. Naidich, USA

9.00 – 9.30

Normal cerebral vessels walls : histology, biology, perivascular spaces

M. Catala, France

9.30 – 10.00

Normal cerebral vascular wall ageing-arteries and veins

W.E Sonntag, USA

10.00 – 10.30

Intracranial vasa vasorum. Implication in neurovascular diseases Including atherosclerosis

B. Wasserman, USA

10.30 – 11.00

Coffee break

11.00 – 11.30

Vessel Wall inflammation and consequences

P. Berlit, Germany

11.30 – 12.00

Vessel wall imaging: from normal to pathological

B. T. Naidich, USA

12.00 – 12.30

Intracranial dissections and therapeutic considerations

G. Rodesch, France

12.30 – 13.30

Lunch break

13.30 – 14.00

Genetic aspects of congenital vasculopathies including HHT

M. Vikkula, Belgium

14.00 – 14.30

Phenotypic aspects of inherited vasculopathies : vascular Ehlers Danlos syndrome

X. Jeunemaître, France

14.30 – 15.00

Phenotypic aspects of congenital vasculopathies : HHT

S. Dupuis Girod, France

15.00 – 15.30

Coffee break

15.30 – 16.00

Specificities of endovascular treatments in congenital vasculopathies

A. Berenstein, USA

16.00- 16.30

Intracranial arteries stenosis : treatments

M. Marks, USA

16.30 – 17.00

Endovascular treatments: consequences on vessel walls

H. Benamer, France

17.00 – 17.30

Embolic materials and vascular wall

P. Gobin, USA

Tuesday 15 September 2020

8.00 – 8.30

Welcome

8.30 – 9.00

Metameric origin of cerebral arteries

M. Tanaka, Japan

9.00 – 9.30

Shear stress and vascular wall

G. Finet, France

9.30 – 10.00

Aneurysmal vasculopathy : from unrupture to rupture

J. Frosen, Finland

10.00 – 10.30

Aneurysmal wall imaging

R. VandenBerg, Netherlands

10.30 – 11.00

Discussion and round table : impact in pre therapeutic aneurysm assessment

M. Soderman, Sweden

11.00 – 11.30

Coffee break

11.30 – 12.30

Role of vessel wall in unruptured to ruptured cerebral AVMs

S. Hetts, USA

12.30 – 13.00

 

Angiogenesis and brain AVMs

A. Berenstein, USA

12.30 – 13.00

Angiogenesis in pediatric population and recurrence of AVMs

D. Orbach, USA

13.00 – 13.30

Cerebral proliferative angiopathies

A. Valavanis, Switzerland

13.30 – 14.30

Lunch break

14.30 – 15.00

Discussion and round table: impact in pre therapeutic cerebral AVMs assessment

S. Bracard, France

15.00 – 15.30

CAMS and angiogenesis in the maxillofacial area

L. Boon, Belgium

15.30 – 16.00

Angiogenesis in Moya moya and progressive arterial stenosis

M. Komiyama, Japan

16.00 – 16.30

Anti angiogenic treatments

L. Boon, Belgium

16.30 – 17.00

Cerebral collateral circulation

G. Rodesch, France

17.00

Conclusions and End of the Seminar

en_US
fr_FR en_US